Stockscreener 앱 받기
240.38
1.42%
3.37
시간 외 거래:
242.90
2.52
+1.05%
전일 마감가:
$237.01
열려 있는:
$234.77
하루 거래량:
928.09K
Relative Volume:
1.02
시가총액:
$16.92B
수익:
$2.36B
순이익/손실:
$236.10M
주가수익비율:
73.15
EPS:
3.286
순현금흐름:
$382.50M
1주 성능:
-2.07%
1개월 성능:
-2.11%
6개월 성능:
-31.87%
1년 성능:
-4.54%
1일 변동 폭
$234.66
$241.13
1주일 범위
$233.29
$247.60
52주 변동 폭
$230.05
$354.88
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
Compare PODD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
240.38 | 16.68B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
112.65 | 190.38B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
365.92 | 139.51B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
91.34 | 116.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.90 | 105.88B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.26 | 47.42B | 6.07B | 1.06B | 1.34B | 1.8063 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 재개 | TD Cowen | Hold |
| 2026-01-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-12-16 | 개시 | Evercore ISI | Outperform |
| 2025-11-19 | 업그레이드 | UBS | Neutral → Buy |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 재개 | Oppenheimer | Outperform |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-05-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-07 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
Published on: 2026-03-09 05:40:12 - baoquankhu1.vn
Insulet stock: Is the Omnipod maker your next stealth growth play? - AD HOC NEWS
Insulet Corporation (PODD) Finalizes Severance Agreement with Fo - GuruFocus
Fisher Asset Management LLC Has $14.29 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Insulet Finalizes Severance Terms for Departing CFO - TipRanks
Former Insulet (NASDAQ: PODD) CFO Ana Chadwick signs severance deal - Stock Titan
Mass. biotech giants added workers in 2025 despite industry-wide layoffs - The Business Journals
Insulet (PODD) SVP Prem Singh reports tax-withholding share transactions - Stock Titan
Insulet (PODD) SVP uses 253 shares to cover RSU tax withholding - Stock Titan
Insulet (PODD) executive records Form 4 tax-withholding share dispositions - Stock Titan
Insulet Corp (NASDAQ: PODD) SVP withholds 605 shares for taxes - Stock Titan
Insulet (PODD) EVP and COO logs tax-withholding share moves in Form 4 - Stock Titan
Insulet Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Segall Bryant & Hamill LLC Boosts Position in Insulet Corporation $PODD - MarketBeat
CI Investments Inc. Grows Stock Position in Insulet Corporation $PODD - MarketBeat
William Blair Investment Management LLC Sells 289,636 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation (PODD) Stock Analysis: Exploring a Promising 43.71% Upside in the Medical Devices Sector - DirectorsTalk Interviews
TD Asset Management Inc Has $12.22 Million Stake in Insulet Corporation $PODD - MarketBeat
Insulet Corporation (NASDAQ:PODD) Short Interest Down 21.8% in February - MarketBeat
Insulet Corporation $PODD Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Strong Revenue Growth And Upbeat 2026 Outlook Might Change The Case For Investing In Insulet (PODD) - simplywall.st
PODD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Quantbot Technologies LP Cuts Position in Insulet Corporation $PODD - MarketBeat
American Century Companies Inc. Sells 106,813 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation's 10th Straight Year Above 20% Revenue Growth Raises Expectations - Smartkarma
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Westfield Capital Management Co. LP Sells 11,362 Shares of Insulet Corporation $PODD - MarketBeat
Integrated Advisors Network LLC Purchases 6,177 Shares of Insulet Corporation $PODD - MarketBeat
Primecap Management Co. CA Cuts Stock Position in Insulet Corporation $PODD - MarketBeat
Intech Investment Management LLC Boosts Stock Holdings in Insulet Corporation $PODD - MarketBeat
Andra AP fonden Buys 28,800 Shares of Insulet Corporation $PODD - MarketBeat
Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating - Finviz
Insulet: The Growth Doesn't Stop Here - Seeking Alpha
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet (PODD) SVP Prem Singh receives equity awards and withholds shares for taxes - Stock Titan
Insulet (PODD) SVP granted RSUs, stock options and withholds shares for taxes - Stock Titan
Insulet (PODD) CAO logs RSU grant, options and tax share withholding - Stock Titan
Equity awards and tax withholding for Insulet (PODD) SVP Kapples - Stock Titan
Insulet (NASDAQ: PODD) COO granted stock and options, withholds shares - Stock Titan
Insulet Corp (PODD) grants stock and option awards to HR chief - Stock Titan
Equity awards for INSULET CORP (PODD) EVP & CFO Flavia Pease - Stock Titan
[Form 4] INSULET CORP Insider Trading Activity - Stock Titan
Discipline and Rules-Based Execution in PODD Response - Stock Traders Daily
Eye On Growth: MICHAEL MINOGUE Adds $499K Of Insulet Stock To Portfolio - Benzinga
Insulet (NASDAQ:PODD) Director Michael Minogue Acquires 2,030 Shares of Stock - MarketBeat
Citigroup Inc. Lowers Stake in Insulet Corporation $PODD - MarketBeat
Insulet Hit With Suit Over 401(k) American Century Funds (1) - Bloomberg Law News
Assessing Insulet (PODD) Valuation After Recent Share Price Weakness And High P/E Multiple - simplywall.st
P/E Ratio Insights for Insulet - Benzinga
Fox Run Management L.L.C. Buys 4,813 Shares of Insulet Corporation $PODD - MarketBeat
Auditor shift at Insulet (NASDAQ: PODD) as Grant Thornton exits - Stock Titan
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
0.94%
자본화:
|
볼륨(24시간):